246 related articles for article (PubMed ID: 18279660)
1. Lipid rafts are involved in SARS-CoV entry into Vero E6 cells.
Lu Y; Liu DX; Tam JP
Biochem Biophys Res Commun; 2008 May; 369(2):344-9. PubMed ID: 18279660
[TBL] [Abstract][Full Text] [Related]
2. Sequestration of membrane cholesterol by cholesterol-binding proteins inhibits SARS-CoV-2 entry into Vero E6 cells.
Kulma M; Šakanović A; Bedina-Zavec A; Caserman S; Omersa N; Šolinc G; Orehek S; Hafner-Bratkovič I; Kuhar U; Slavec B; Krapež U; Ocepek M; Kobayashi T; Kwiatkowska K; Jerala R; Podobnik M; Anderluh G
Biochem Biophys Res Commun; 2024 Jul; 716():149954. PubMed ID: 38704887
[TBL] [Abstract][Full Text] [Related]
3. Cholesterol-Rich Lipid Rafts as Platforms for SARS-CoV-2 Entry.
Palacios-Rápalo SN; De Jesús-González LA; Cordero-Rivera CD; Farfan-Morales CN; Osuna-Ramos JF; Martínez-Mier G; Quistián-Galván J; Muñoz-Pérez A; Bernal-Dolores V; Del Ángel RM; Reyes-Ruiz JM
Front Immunol; 2021; 12():796855. PubMed ID: 34975904
[TBL] [Abstract][Full Text] [Related]
4. Lipid rafts as viral entry routes and immune platforms: A double-edged sword in SARS-CoV-2 infection?
Roncato R; Angelini J; Pani A; Talotta R
Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Jun; 1867(6):159140. PubMed ID: 35248801
[TBL] [Abstract][Full Text] [Related]
5. Lipid raft disruption by cholesterol depletion enhances influenza A virus budding from MDCK cells.
Barman S; Nayak DP
J Virol; 2007 Nov; 81(22):12169-78. PubMed ID: 17855515
[TBL] [Abstract][Full Text] [Related]
6. Targeting Lipid Rafts as a Strategy Against Coronavirus.
Sorice M; Misasi R; Riitano G; Manganelli V; Martellucci S; Longo A; Garofalo T; Mattei V
Front Cell Dev Biol; 2020; 8():618296. PubMed ID: 33614627
[TBL] [Abstract][Full Text] [Related]
7. Co-Expression of Niemann-Pick Type C1-Like1 (NPC1L1) with ACE2 Receptor Synergistically Enhances SARS-CoV-2 Entry and Fusion.
Elste J; Cast N; Udawatte S; Adhikari K; Payen SH; Verma SC; Shukla D; Swanson-Mungerson M; Tiwari V
Biomedicines; 2024 Apr; 12(4):. PubMed ID: 38672177
[TBL] [Abstract][Full Text] [Related]
8. Lipid rafts disruption by statins negatively impacts the interaction between SARS-CoV-2 S1 subunit and ACE2 in intestinal epithelial cells.
El Khoury M; Naim HY
Front Microbiol; 2023; 14():1335458. PubMed ID: 38260879
[TBL] [Abstract][Full Text] [Related]
9. Hydroxychloroquine: mechanism of action inhibiting SARS-CoV2 entry.
Yuan Z; Pavel MA; Wang H; Hansen SB
bioRxiv; 2020 Oct; ():. PubMed ID: 32817933
[TBL] [Abstract][Full Text] [Related]
10. The role of high cholesterol in age-related COVID19 lethality.
Wang H; Yuan Z; Pavel MA; Jablonski SM; Jablonski J; Hobson R; Valente S; Reddy CB; Hansen SB
bioRxiv; 2021 Jun; ():. PubMed ID: 32511366
[TBL] [Abstract][Full Text] [Related]
11. Mechanobiology predicts raft formations triggered by ligand-receptor activity across the cell membrane.
Carotenuto AR; Lunghi L; Piccolo V; Babaei M; Dayal K; Pugno N; Zingales M; Deseri L; Fraldi M
J Mech Phys Solids; 2020 Aug; 141():103974. PubMed ID: 32461703
[TBL] [Abstract][Full Text] [Related]
12. Host Membranes as Drivers of Virus Evolution.
Matveeva M; Lefebvre M; Chahinian H; Yahi N; Fantini J
Viruses; 2023 Aug; 15(9):. PubMed ID: 37766261
[TBL] [Abstract][Full Text] [Related]
13. CLN7/MFSD8 may be an important factor for SARS-CoV-2 cell entry.
Heinl ES; Lorenz S; Schmidt B; Nasser M Laqtom N; Mazzulli JR; Francelle L; Yu TW; Greenberg B; Storch S; Tegtmeier I; Othmen H; Maurer K; Steinfurth M; Witzgall R; Milenkovic V; Wetzel CH; Reichold M
iScience; 2022 Oct; 25(10):105082. PubMed ID: 36093380
[TBL] [Abstract][Full Text] [Related]
14. Importance of cholesterol-rich membrane microdomains in the interaction of the S protein of SARS-coronavirus with the cellular receptor angiotensin-converting enzyme 2.
Glende J; Schwegmann-Wessels C; Al-Falah M; Pfefferle S; Qu X; Deng H; Drosten C; Naim HY; Herrler G
Virology; 2008 Nov; 381(2):215-21. PubMed ID: 18814896
[TBL] [Abstract][Full Text] [Related]
15. Detection of a common feature in several human tumor cell lines--a 53,000-dalton protein.
Crawford LV; Pim DC; Gurney EG; Goodfellow P; Taylor-Papadimitriou J
Proc Natl Acad Sci U S A; 1981 Jan; 78(1):41-5. PubMed ID: 6264441
[TBL] [Abstract][Full Text] [Related]
16. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV.
Ou X; Liu Y; Lei X; Li P; Mi D; Ren L; Guo L; Guo R; Chen T; Hu J; Xiang Z; Mu Z; Chen X; Chen J; Hu K; Jin Q; Wang J; Qian Z
Nat Commun; 2020 Mar; 11(1):1620. PubMed ID: 32221306
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol in Relation to COVID-19: Should We Care about It?
Radenkovic D; Chawla S; Pirro M; Sahebkar A; Banach M
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32570882
[TBL] [Abstract][Full Text] [Related]
18. Cell entry mechanisms of SARS-CoV-2.
Shang J; Wan Y; Luo C; Ye G; Geng Q; Auerbach A; Li F
Proc Natl Acad Sci U S A; 2020 May; 117(21):11727-11734. PubMed ID: 32376634
[TBL] [Abstract][Full Text] [Related]
19. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells.
Wang K; Chen W; Zhang Z; Deng Y; Lian JQ; Du P; Wei D; Zhang Y; Sun XX; Gong L; Yang X; He L; Zhang L; Yang Z; Geng JJ; Chen R; Zhang H; Wang B; Zhu YM; Nan G; Jiang JL; Li L; Wu J; Lin P; Huang W; Xie L; Zheng ZH; Zhang K; Miao JL; Cui HY; Huang M; Zhang J; Fu L; Yang XM; Zhao Z; Sun S; Gu H; Wang Z; Wang CF; Lu Y; Liu YY; Wang QY; Bian H; Zhu P; Chen ZN
Signal Transduct Target Ther; 2020 Dec; 5(1):283. PubMed ID: 33277466
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
